Clinical Trial

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A study to evaluate the safety and tolerability of INCA036873 in participants with advanced solid tumors and hematological malignancies.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-09-19; most recent amendment 2026-06-29.
Status change: Not Yet Recruiting → Recruiting 2026-01-22
Trial Details
NCT Number NCT07195916
Lead Sponsor Incyte Corporation
Conditions Solid Tumors, Hematologic Malignancies
Enrollment 280 participants
Start Date 2026-01-08
Primary Completion 2028-08-18 (estimated)
Study Completion 2028-08-18 (estimated)
Updated on ClinicalTrials.gov 2026-08-06